Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Jayaraja Kumar Kalaimani"'
Autor:
Vijayan Venugopal, Shalini Krishnan, Vasanth Raj Palanimuthu, Subin Sankarankutty, Jayaraja Kumar Kalaimani, Sundram Karupiah, Ng Siew Kit, Tang Thean Hock
Publikováno v:
PLoS ONE, Vol 13, Iss 11, p e0206109 (2018)
The aim of the present study is to analyze the viability of anti-EGFR anchored immunonanoparticle (INP) bearing Paclitaxel (PTX) to specifically bind the EGFR protein on the TNBC cells. The NP was prepared by nanoprecipitation and characterized the p
Externí odkaz:
https://doaj.org/article/44c03fae9e23451c94590946d4b172bb
Autor:
Muralidharan, Selvadurai1 murali23pharm@hotmail.com, Jayaraja kumar, Kalaimani2, Parasuraman, Subramani3
Publikováno v:
Journal of Young Pharmacists. 2013, Vol. 5 Issue 3, p98-101. 4p.
Autor:
Tang Thean Hock, Shalini Krishnan, Vijayan Venugopal, Sundram Karupiah, Subin Sankarankutty, Ng Siew Kit, Jayaraja Kumar Kalaimani, Vasanth Raj Palanimuthu
Publikováno v:
Venugopal, V, Krishnan, S, Palanimuthu, V R, Sankarankutty, S, Kalaimani, J K, Karupiah, S, Kit, N S & Hock, T T 2018, ' Anti-EGFR anchored paclitaxel loaded PLGA nanoparticles for the treatment of triple negative breast cancer. In-vitro and in-vivo anticancer activities ', PLoS ONE, vol. 13, no. 11, e0206109 . https://doi.org/10.1371/journal.pone.0206109
PLoS ONE
PLoS ONE, Vol 13, Iss 11, p e0206109 (2018)
PLoS ONE
PLoS ONE, Vol 13, Iss 11, p e0206109 (2018)
The aim of the present study is to analyze the viability of anti-EGFR anchored immunonanoparticle (INP) bearing Paclitaxel (PTX) to specifically bind the EGFR protein on the TNBC cells. The NP was prepared by nanoprecipitation and characterized the p